This blog is closed to new posts due to inactivity. The post remains here as part of the network’s archive of useful research information. We hope you'll join the conversation by posting to an open topic or starting a new one.
 
Dear All,
I thought I should draw attention to a paper published in PLoS Medicine Journal last week with the above title.
I am one of the authors in the multi-author, multi-country paper on the global topical issue of publication misconduct. Every country discusses the challenge but only some High Income countries have gone further to institute regulations against such practice. To our knowledge amongst Low and Middle Income Countries (LMICs)only China  has risen to the challenge on a nation-wide scale. In view of the damage that publication misconduct poses to the sanctity of world literature from which practitioners get material for evidence based practice, and the potential that wrong material may lead to loss of life, we advocate further study of the prolem in LMICs and that every LMICs should go beyond mere discussion to enacting laws against publication misconduct.
The direct URL for the paper is:
Ana J, Koehlmoos T, Smith R, Yan LL (2013) Research Misconduct in Low- and Middle-Income Countries. PLoS Med 10(3): e1001315. doi:10.1371/journal.pmed.1001315
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001315
 
Joseph Ana.
 

  • yclaeys Yves Claeys 10 Apr 2013

    Dear Joseph,
    Thank you for this article!! Although misconduct can take place during many stages of a clinical trial, data management must play it's role as a preventive action; not only with audit trail proof software and system engineering but with adequate time and resourses put on in depth data review and site monitoring. It is only one piece of the puzzle but an important one, generally with room for improvement

  • rravinetto Raffaella Ravinetto 5 Apr 2013

    Dear Joseph,

    this is a very interesting and important article! Do you think that these kind of findings could contribute to inform the long-awaited revision of the current WHO GCP Guidelines (issued in 1995), in order to include specific mentions of research integrity as well as measures to try to prevent them?

    Raffaella